中文

WEST PHARMACEUTICAL SERVICES INC Revenue Breakdown

Period 2026-06-30 (quarterly) ・ Reported 2026-07-23
ItemAmountY/Y
Revenue$0.87B+13.8%
Gross profit$0.33B
Operating income$0.18B
Net income$0.15B+16.8%
Gross margin37.7%Net margin 17.7%
Revenue Q/Q+3.2%

Revenue Segments

SegmentRevenueShare
Proprietary Products$0.72B82.8%
West Vantage$0.15B17.2%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$0.54B62.3%
R&D$0.02B2.3%
SG&A$0.12B13.5%
Tax & other$0.03B2.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

WDCWYWSMWMBWTWWDAYWYNNXELXYLYUMZBRAZBH

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies